The Endocannabinoid System May Modulate Sleep Disorders in Aging

Current Neuropharmacology
Eric Murillo-RodriguezPablo Torterolo

Abstract

Aging is an inevitable process that involves changes across life in multiple neurochemical, neuroanatomical, hormonal systems, and many others. In addition, these biological modifications lead to an increase in age-related sickness such as cardiovascular diseases, osteoporosis, neurodegenerative disorders, and sleep disturbances, among others that affect activities of daily life. Demographic projections have demonstrated that aging will increase its worldwide rate in the coming years. The research on chronic diseases of the elderly is important to gain insights into this growing global burden. Novel therapeutic approaches aimed for treatment of age-related pathologies have included the endocannabinoid system as an effective tool since this biological system shows beneficial effects in preclinical models. However, and despite these advances, little has been addressed in the arena of the endocannabinoid system as an option for treating sleep disorders in aging since experimental evidence suggests that some elements of the endocannabinoid system modulate the sleep-wake cycle. This article addresses this less-studied field, focusing on the likely perspective of the implication of the endocannabinoid system in the regulation of slee...Continue Reading

References

Sep 28, 1998·Biochimica Et Biophysica Acta·F BerrenderoJ J Fernández-Ruiz
Nov 14, 1998·Brain Research·E Murillo-RodríguezO Prospéro-García
Jun 8, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·D G DeutschS Yamamoto
Apr 20, 2004·Cellular and Molecular Life Sciences : CMLS·M ValentiV Di Marzo
Mar 6, 2007·European Journal of Pharmacology·Eric Murillo-RodríguezRené Drucker-Colin
Oct 17, 2008·Radiologic Clinics of North America·Luigi FerrucciJack M Guralnik
Apr 30, 2010·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·R JumpertzM Stumvoll
May 7, 2011·Neurobiology of Aging·Rolf FronczekDick F Swaab
Sep 17, 2011·Central Nervous System Agents in Medicinal Chemistry·Eric Murillo-RodriguezGloria Arankowsky-Sandoval
Dec 24, 2011·The Lancet Infectious Diseases·Jon E Rohde
Apr 25, 2012·Central Nervous System Agents in Medicinal Chemistry·Eric Murillo-RodriguezGloria Arankowsky-Sandoval
Jun 22, 2012·PloS One·Claudio D'AddarioMauro Maccarrone
Jun 26, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Rahul R Deshmukh, P L Sharma
Oct 4, 2012·Journal of Hypertension·Stefan EngeliJens Jordan
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Andras Bilkei-Gorzo
Jun 12, 2013·Maturitas·Alexandra M WennbergAdam P Spira
Jun 27, 2013·Schizophrenia Research·Carolina MuguruzaLuis F Callado
Jul 5, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Miquel BioqueUNKNOWN FLAMM-PEPs study—Centro de Investigacio´n Biome´dica en Red de Salud Mental
Apr 29, 2014·Experimental Gerontology·Ana C PascualSusana J Pasquaré
May 8, 2014·Neuroscience Research·Stephanie Mijangos-MorenoEric Murillo-Rodríguez
Aug 26, 2014·Journal of Alzheimer's Disease : JAD·Gaurav BedseSilvana Gaetani
Nov 26, 2014·The Journal of Experimental Medicine·Jee Hoon RohDavid M Holtzman
Dec 3, 2014·Ageing Research Reviews·Joshua P NixonJennifer A Teske
Dec 17, 2014·Lancet Neurology·Isabelle Arnulf
Dec 17, 2014·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Tasnime N AkbaralyYves Dauvilliers
Jan 31, 2015·Journal of Cardiovascular Pharmacology·Chris L SchaichDebra I Diz
Mar 23, 2015·Trends in Pharmacological Sciences·Mauro MaccarroneAndreas Zimmer
May 20, 2015·Lancet Neurology·Kai Spiegelhalder, Dieter Riemann
Jul 19, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Angélica Pupin SchiavonRúbia Maria Weffort de Oliveira
Aug 13, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Clementino Ibeas BihBenjamin J Whalley
Aug 19, 2015·Mechanisms of Ageing and Development·Anastasia PiyanovaAndras Bilkei-Gorzo
Sep 12, 2015·The Lancet. Psychiatry·Matcheri S KeshavanTomáš Paus
Sep 13, 2015·Neurobiology of Aging·Carmen VázquezJulián Romero
Sep 24, 2015·British Journal of Pharmacology·William J RedmondMark Connor
Sep 27, 2015·Handbook of Experimental Pharmacology·Roger G Pertwee

❮ Previous
Next ❯

Citations

Apr 11, 2021·Molecular Psychiatry·Alexandre ValléeJean-Noël Vallée
May 13, 2021·The FEBS Journal·Almudena Robledo-MenendezEdgar Soria-Gomez
Aug 21, 2021·Frontiers in Physiology·Daniel Rojas-Valverde

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Related Papers

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
Andras Bilkei-Gorzo
CNS & Neurological Disorders Drug Targets
J Romero, J Martínez Orgado
Srpski arhiv za celokupno lekarstvo
Tatjana Smiljković
© 2021 Meta ULC. All rights reserved